We are live on ! Find out more
EAR

Eargo

Delisted

EAR was delisted on the 15th of February, 2024.

0 hedge funds and large institutions have $0 invested in Eargo in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

82.14% less ownership

Funds ownership: 82.14% → 0% (-82%)

100% less funds holding

Funds holding: 23 → 0 (-23)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less capital inflows, than outflows

Capital inflows: $0 | Capital outflows: $44.2M

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 23

Holders
–
Holders Change
-23
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
23
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

EAR Hedge Fund Activity: Q1 2024 in Review

0 of the 6,969 institutional investors tracked by Wall St. Rank reported a position in Eargo (EAR) for Q1 2024, worth a combined $0 — down 100% from $44.2M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of EAR and 0 opened new positions — a net loss of 23 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Patient Square Capital, exiting entirely with an estimated $41M sold.

  • 0 institutional investors held Eargo (EAR) as of Q1 2024, down from 23 in Q4 2023.
  • Funds reported $0 of Eargo stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Eargo positions in Q1 2024 and 23 closed out, a net change of -23 holders.
  • The largest Eargo seller in Q1 2024 was Patient Square Capital, an estimated $41M sold.

Based on aggregated 13F filings for Q1 2024.